OSIMERTINIB vs OSPEMIFENE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OSIMERTINIB vs OSPEMIFENE: Safety Overview
| Metric | OSIMERTINIB | OSPEMIFENE |
|---|---|---|
| Total FAERS Reports | 27,750 | 2,047 |
| Deaths Reported | 12,456 | 2 |
| Death Rate | 44.9% | 0.1% |
| Hospitalizations | 5,277 | 60 |
| Average Patient Age | 68.2 yrs | 61.7 yrs |
| % Female Patients | 66.0% | 99.8% |
| FDA Approval Date | Nov 13, 2015 | Feb 13, 2024 |
| Manufacturer | AstraZeneca Pharmaceuticals LP | Duchesnay USA, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |